RIETE Score for Risk of Hemorrhage in Pulmonary Embolism Treatment

Determines the risk of major bleeding during anticoagulant therapy for pulmonary embolism.

Recent Major Bleeding

Creatinine > 1.2 mg/dL (106.1 µmol/L)

Anemia

  • Hgb <13 g/dL for Men
  • Hgb <12 g/dL for Women

Malignancy History

Clinically-overt Pulmonary Embolism

Age > 75

Interpretation

Source: Ruíz-Giménez N, Suárez C, González R, Nieto JA, Todolí JA, Samperiz AL, Monreal M; RIETE Investigators. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost. 2008 Jul;100(1):26-31. doi: 10.1160/TH08-03-0193.
Copy Results Reset Print